Humacyte (HUMA) Gross Profit (2025 - 2026)
Humacyte (HUMA) reported Gross Profit of -$1.5 million for Q1 2026, down 517.03% year-over-year from $370000.0 in Q1 2025, and up 82.09% quarter-over-quarter from -$8.6 million in Q4 2025.
Humacyte (HUMA) Gross Profit (2025 - 2026) Analysis & Trends
Humacyte (HUMA) has 2 years of Gross Profit data on file, last reported at -$1.5 million in Q1 2026.
- Gross Profit for Q1 2026 came in at -$1.5 million, down 517.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.6 million (down 2688.38% YoY), and the FY2025 annual result was -$7.7 million, changed N/A from the prior year.
- Gross Profit improved to -$1.5 million in Q1 2026 per HUMA's latest filing, from -$8.6 million in the prior quarter.
- Over five years, Gross Profit peaked at $493000.0 in Q3 2025 and troughed at -$8.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Humacyte | 183.21 Mn | 134.67 Mn | -1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.54 Mn |
| Mar 31, 2026 | -1.54 Mn |
| Dec 31, 2025 | -8.62 Mn |
| Dec 31, 2025 | -8.62 Mn |
| Sep 30, 2025 | 493,000.00 |
| Sep 30, 2025 | 493,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 88,000.00 |
| Mar 31, 2025 | 370,000.00 |
| Mar 31, 2025 | 370,000.00 |